{"schema_version":"secwatch.filing_event.v1","accession":"0001127537-24-000012","form_type":"8-K","ticker":"LUNG","cik":"0001127537","company_name":"Pulmonx Corp","filed_at":"2024-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.469681+00:00","generated_at":"2026-06-05T21:42:02.858596+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Pulmonx CEO Glen French retires; Steve Williamson appointed President and CEO effective March 15, 2024","bullets":["Glen French resigns as CEO effective March 15; will serve as Senior Advisor until May 1, then remain on Board.","Steve Williamson named CEO and Board member; previously Chief Commercial Officer at Outset Medical.","Williamson receives $580k base salary, 75% target bonus, and equity grants totaling $5M (option + RSU).","Board reduces size to eight directors after Alissa Hsu Lynch declines re-election at 2024 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001127537-24-000012","json":"https://secwatch.observer/filing/0001127537-24-000012.json","markdown":"https://secwatch.observer/filing/0001127537-24-000012.md","text":"https://secwatch.observer/filing/0001127537-24-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1127537/000112753724000012/0001127537-24-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1127537/000112753724000012/lung-20240221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T21:42:02.858596+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"32d8f8b649","claim":"Glendon E. French resigned as President and Chief Executive Officer at Pulmonx Corp.","evidence_excerpt":"On February 20, 2024, Glendon E. French resigned as President and Chief Executive Officer of Pulmonx Corporation (the “Company”), effective as of March 15, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1127537/000112753724000012/0001127537-24-000012-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"aaa65f629e","claim":"Steven S. Williamson was appointed as President and Chief Executive Officer at Pulmonx Corp.","evidence_excerpt":"On February 19, 2024, the Company’s board of directors appointed Steven S. Williamson as the Company’s President and Chief Executive Officer and a Class II member of the board of directors, each as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1127537/000112753724000012/0001127537-24-000012-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}